Some of these hydrolysates also exerted antioxidant effects, improved HTN-associated endothelial dysfunction, and reduced ACE activity in different in vivo hypertensive models, which may contribute to their antihypertensive activity. The gene discussed is ACE; the disease is hypertensive disorder.